TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 94 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,138,138 | -42.7% | 1,617,920 | -0.2% | 0.11% | -40.8% |
| Q2 2023 | $14,190,566 | -51.5% | 1,621,779 | -34.3% | 0.18% | -56.3% |
| Q1 2023 | $29,239,022 | +25.2% | 2,469,512 | +7.6% | 0.41% | +17.8% |
| Q4 2022 | $23,356,748 | +148.2% | 2,294,376 | +43.6% | 0.35% | +143.4% |
| Q3 2022 | $9,412,000 | +1706.5% | 1,597,929 | +660.7% | 0.14% | +1687.5% |
| Q2 2022 | $521,000 | +401.0% | 210,074 | +498.5% | 0.01% | +700.0% |
| Q1 2022 | $104,000 | – | 35,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |